A FinnGen pilot clinical recall study for Alzheimer’s disease
View ORCID ProfileValtteri Julkunen, Claudia Schwarz, Juho Kalapudas, Merja Hallikainen, Aino-Kaisa Piironen, Arto Mannermaa, Hanna Kujala, Timo Laitinen, Veli-Matti Kosma, Teemu I. Paajanen, Reetta Kälviäinen, Mikko Hiltunen, Sanna-Kaisa Herukka, Sari Kärkkäinen, Tarja Kokkola, Mia Urjansson, Finn Gen, Markus Perola, Aarno Palotie, Eero Vuoksimaa, Heiko Runz
doi: https://doi.org/10.1101/2023.02.06.23285534
Valtteri Julkunen
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
2Department of Neurology, Neurocenter, Kuopio University Hospital, Kuopio, Finland Biogen, Cambridge, MA, USA
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland Biogen, Cambridge, MA, USA
Claudia Schwarz
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland Biogen, Cambridge, MA, USA
4Department of Neurology, University Medicine Greifswald, Greifswald, Germany Biogen, Cambridge, MA, USA
Juho Kalapudas
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Merja Hallikainen
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Aino-Kaisa Piironen
5Biobank of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Arto Mannermaa
5Biobank of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Hanna Kujala
5Biobank of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Timo Laitinen
5Biobank of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Veli-Matti Kosma
5Biobank of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Teemu I. Paajanen
6Work Ability and Working Careers, Finnish Institute of Occupational Health, Helsinki, Finland Biogen, Cambridge, MA, USA
Reetta Kälviäinen
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Mikko Hiltunen
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Sanna-Kaisa Herukka
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Sari Kärkkäinen
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Tarja Kokkola
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Mia Urjansson
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland Biogen, Cambridge, MA, USA
Finn Gen
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland Biogen, Cambridge, MA, USA
Markus Perola
7Finnish Institute for Health and Welfare (THL), Helsinki, Finland Biogen, Cambridge, MA, USA
Aarno Palotie
8Analytic and Translational Genetics Unit, Department of Medicine, Department of Neurology and Department of Psychiatry Massachusetts General Hospital, Boston, MA, USA
9The Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland Biogen, Cambridge, MA, USA
Eero Vuoksimaa
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland Biogen, Cambridge, MA, USA
Heiko Runz
10Translational Sciences, Biogen, Cambridge, MA, USA
Data Availability
All data produced are available in FinnGen sandbox, a safe controlled environment accessible by authorized researchers in FinnGen research community.
Posted February 08, 2023.
A FinnGen pilot clinical recall study for Alzheimer’s disease
Valtteri Julkunen, Claudia Schwarz, Juho Kalapudas, Merja Hallikainen, Aino-Kaisa Piironen, Arto Mannermaa, Hanna Kujala, Timo Laitinen, Veli-Matti Kosma, Teemu I. Paajanen, Reetta Kälviäinen, Mikko Hiltunen, Sanna-Kaisa Herukka, Sari Kärkkäinen, Tarja Kokkola, Mia Urjansson, Finn Gen, Markus Perola, Aarno Palotie, Eero Vuoksimaa, Heiko Runz
medRxiv 2023.02.06.23285534; doi: https://doi.org/10.1101/2023.02.06.23285534
A FinnGen pilot clinical recall study for Alzheimer’s disease
Valtteri Julkunen, Claudia Schwarz, Juho Kalapudas, Merja Hallikainen, Aino-Kaisa Piironen, Arto Mannermaa, Hanna Kujala, Timo Laitinen, Veli-Matti Kosma, Teemu I. Paajanen, Reetta Kälviäinen, Mikko Hiltunen, Sanna-Kaisa Herukka, Sari Kärkkäinen, Tarja Kokkola, Mia Urjansson, Finn Gen, Markus Perola, Aarno Palotie, Eero Vuoksimaa, Heiko Runz
medRxiv 2023.02.06.23285534; doi: https://doi.org/10.1101/2023.02.06.23285534
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12780)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4608)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2938)
- Health Policy (1070)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4387)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6978)
- Radiology and Imaging (1538)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)